Johnson & Johnson and Global Partners Announce Results from

Johnson & Johnson and Global Partners Announce Results from Phase 2b Imbokodo HIV Vaccine Clinical Trial in Young Women in Sub-Saharan Africa

Johnson & Johnson and Global Partners Announce Results from Phase 2b Imbokodo HIV Vaccine Clinical Trial in Young Women in Sub-Saharan Africa

apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

South Africa , Malawi , Mozambique , New Horizons , Western Cape , Zambia , Zimbabwe , Paul Stoffels , Dan Barouch , Prnewswire Johnson , Glenda Gray , National Institute Of Allergy , Ragon Institute , Melinda Gates Foundation , Janssen Pharmaceutical Companies , Janssen Pharmaceutical Companies Of Johnson , Menstar Coalition , International Partnership For Microbicides , Vaccine Trials Network , Development Command , None Of The Janssen Pharmaceutical Companies , National Institutes Of Health , Us Army Medical Research , European Commission , World Health Organization , Drug Administration , Exchange Commission , Companies Of Johnson , Vaccine Development , Johnson , African Medical Research Council , Saharan Africa , Safety Monitoring Board , Vice Chairman , Executive Committee , Chief Scientific Officer , Professor Glenda Gray , Chief Executive Officer , South African Medical Research Council , Imbokodo Study , Janssen Vaccines , National Institute , Infectious Diseases , National Institutes , Trials Network , Medical Research , Principal Investigator , Viiv Healthcare , New Drug Application , International Partnership , Pharmaceutical Companies , Protocol Chair , Private Securities Litigation Reform Act , Annual Report , Note Regarding Forward Looking , Quarterly Report , Fact Sheet ,